Sippy B D, Hofman F M, Wright A D, Wang J L, Gopalakrishna R, Gundimeda U, He S, Ryan S J, Hinton D R
Department of Pathology, University of Southern California School of Medicine, Los Angeles, 90033, USA.
Invest Ophthalmol Vis Sci. 1996 Mar;37(4):597-606.
To determine second messenger signaling pathways associated with tumor necrosis factor-alpha (TNF)-mediated induction of intercellular adhesion molecule (ICAM)-1 expression on human retinal pigment epithelial (HRPE) cells, a cell type known to express only the 55-kDa TNF receptor (TNFR p55).
SV 40-immortalized HRPE (SVRPE) cells were exposed to TNF with and without pretreatment with the protein kinase C (PKC) inhibitor calphostin C or the protein kinase A (PKA) inhibitor H8. SV40-immortalized HRPE cells also were treated with the PKC activator phorbol 12-myristate 13-acetate (PMA) or with the PKA activators forskolin plus 3-isobutyl-1-methyl-xanthine or dibutyryl cyclic adenosine monophosphate (cAMP) alone. Membrane fractions from untreated and treated SVRPE cells were assayed for PKC activity, and whole cell lysates were assayed for cAMP accumulation and PKA activity. Flow cytometry was performed on SVRPE cells using a monoclonal antibody specific to ICAM-1.
Activation of TNFR p55 on SVRPE cells with TNF resulted in a rapid increase of PKC activity at 1 minute, with a subsequent downregulation to baseline. There was no increase in intracellular cAMP accumulation or PKA activity within the first 10 minutes; however, both increased within 30 minutes and returned to baseline within 1 hour. SV40-immortalized HRPE cells treated with TNF for 1 hour showed maximal induction of ICAM-1 expression at 18 hours. ICAM-1 induction by TNF treatment was inhibited by calphostin C pretreatment and not by H8 pretreatment. Protein kinase C activation with PMA for 3 hours was sufficient to induce ICAM-1 on SVRPE cells at 18 hours, whereas treatment with the PKA activators forskolin or dibutyryl cAMP did not induce ICAM-1 expression.
Tumor necrosis factor sequentially activates the PKC and PKA pathways in SVRPE cells by way of the TNFR p55. The PKC pathway in necessary for TNF-mediated ICAM-1 upregulation, and specific activation of the PKC pathway with PMA is sufficient to induce ICAM-1 on these cells. SV40-immortalized HRPE cells may serve as a model in which to study further the functional signaling pathways associated with TNFR p55.
确定与肿瘤坏死因子-α(TNF)介导的人视网膜色素上皮(HRPE)细胞细胞间黏附分子(ICAM)-1表达诱导相关的第二信使信号通路,HRPE细胞是一种已知仅表达55 kDa TNF受体(TNFR p55)的细胞类型。
用蛋白激酶C(PKC)抑制剂钙泊三醇C或蛋白激酶A(PKA)抑制剂H8预处理或不预处理的情况下,将SV40永生化HRPE(SVRPE)细胞暴露于TNF。SV40永生化HRPE细胞也用PKC激活剂佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)或PKA激活剂福斯可林加3-异丁基-1-甲基黄嘌呤或单独的二丁酰环磷酸腺苷(cAMP)处理。对未处理和处理过的SVRPE细胞的膜组分进行PKC活性测定,对全细胞裂解物进行cAMP积累和PKA活性测定。使用针对ICAM-1的单克隆抗体对SVRPE细胞进行流式细胞术检测。
用TNF激活SVRPE细胞上的TNFR p55导致1分钟时PKC活性迅速增加,随后下调至基线。在最初10分钟内细胞内cAMP积累或PKA活性没有增加;然而,两者在30分钟内均增加并在1小时内恢复到基线。用TNF处理1小时的SV40永生化HRPE细胞在18小时时显示出ICAM-1表达的最大诱导。钙泊三醇C预处理可抑制TNF处理诱导的ICAM-1表达,而H8预处理则无此作用。用PMA激活蛋白激酶C 3小时足以在18小时时诱导SVRPE细胞上的ICAM-1表达,而用PKA激活剂福斯可林或二丁酰cAMP处理则不诱导ICAM-1表达。
肿瘤坏死因子通过TNFR p55依次激活SVRPE细胞中的PKC和PKA途径。PKC途径是TNF介导的ICAM-1上调所必需的,用PMA特异性激活PKC途径足以在这些细胞上诱导ICAM-1表达。SV40永生化HRPE细胞可作为进一步研究与TNFR p55相关的功能信号通路的模型。